Mutations that activate Notch receptors (NOTCH1 and NOTCH2) have been detected in a subset of pancreatic cancer cases, leading to ligand-independent activation of Notch signaling (69). This evidence concerns the gene NOTCH2 and pancreatic neoplasm.